Lacour, André
King's College London
7 papers on CoChatORCID 0000-0003-2692-2583
Most cited papers
- Verified
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 2,498
- Verified
Genome-wide association study reveals two new risk loci for bipolar disorder
Mühleisen, T. W., Leber, M., Schulze, T. G., Strohmaier, J., Degenhardt, F., Treutlein, J., Mattheisen, M., Forstner, A. J., Schumacher, J., Breuer, R., et al. (2014) · Nature Communications
Bipolar Disorder and TreatmentGenetic Associations and Epidemiology
Cited by 346
- Verified
A novel Alzheimer disease locus located near the gene encoding tau protein
Jun, G., Ibrahim-Verbaas, C. A., Vronskaya, M., Lambert, J.-C., Chung, J., Naj, A. C., Kunkle, B. W., Wang, L.-S., Bis, J. C., Bellenguez, C., et al. (2016) · Molecular Psychiatry
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 297
- Verified
Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
Lacour, A., Espinosa, A., Louwersheimer, E., Heilmann, S., Hernández, I., Wolfsgruber, S., Fernández, V, Wagner, H., Rosende-Roca, M., Mauleón, A., et al. (2017) · Molecular Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 101
- Verified
Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene
Ruiz, A., Heilmann, S., Becker, T., Hernández, I., Wagner, H., Thelen, M., Mauleón, A., Rosende-Roca, M., Bellenguez, C., Bis, J. C., et al. (2014) · Translational Psychiatry
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 97
- Verified
SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 49
- Verified
O4‐04‐04: TOWARD FINE MAPPING AND FUNCTIONAL CHARACTERIZATION OF GENOME‐WIDE ASSOCIATION STUDY‐IDENTIFIED LOCUS RS74615166 (TRIP4) FOR ALZHEIMER'S DISEASE
Ruiz, A., Heilmann, S., Leber, M., Becker, T., Toliat, M., Royo, J. L., Wagner, H., Thelen, M., Hernandez, I., Alegret, M., et al. (2014) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free